PhoenixBio Co., Ltd. (TSE: 6190)
Health Care · Life Sciences Tools & Services · JP
¥318.00
+1.27% today · -34.8% 1Y
PhoenixBio Co., Ltd. (TSE: 6190) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $8.17M and employs 55 people.
Over the last twelve months the share price has lost 34.8%, trading between 296.00 and 724.00.
Tweenvest scores PhoenixBio Co., Ltd. across four factors: quality 70/100, value 55/100, growth 27/100. Its strongest factor is quality.
6190 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $8.17M
- Revenue (TTM)
- $8.75M
- P/E
- 86.28
- EPS
- 3.69
- Dividend yield
- —
- Beta (5Y)
- 0.37
- 52-week high
- ¥724.00
- 52-week low
- ¥296.00
- Avg volume (3M)
- —
- Shares outstanding
- 4.07M
- Employees
- 55
- Next earnings
- —
About PhoenixBio Co., Ltd.
PhoenixBio Co., Ltd. delivers specialized contract research services to support drug discovery and development, with a primary focus on the Japanese market. Central to its offerings is the proprietary PXB-mouse, a unique chimeric mouse model featuring a humanized liver, which is critical for various drug development experiments. The company also conducts in vitro analyses utilizing fresh human hepatocytes sourced from PXB-cells. This sophisticated humanized liver model proves invaluable for in vivo studies encompassing gene therapy, NASH/NAFLD drug development programs, anti-viral therapeutic evaluations, DMPK (Drug Metabolism and Pharmacokinetics) and toxicity assessments, and custom transplantation projects. Established in 2002, PhoenixBio maintains its headquarters in Higashihiroshima, Japan.
- ISIN
- JP3803010002
- Founded
- 2002
- Listed since
- Mar 18, 2016
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Memphasys LimitedASX: MEM | $10.77M | AU$0.01 | -16.67% |
| China Health Group Inc.SEHK: 8225 | $10.02M | HK$0.08 | +12.86% |
| RBC Bioscience CorporationTPEX: 6848 | $9.55M | NT$21.40 | -0.23% |
| IDL Diagnostics AB (publ)OM: IDLDX | $8.89M | Skr0.39 | +4.32% |
| BioLight Life Sciences Ltd.TASE: BOLT | $7.99M | ₪2.70 | -7.10% |
| Medicofarma Biotech SAWSE: MDB | $6.52M | zł0.38 | +0.53% |
| Ghani Global Glass LimitedKASE: GGGL | $6.48M | PKRs7.51 | -0.27% |
| Proteome Sciences plcAIM: PRM | $6.29M | £0.01 | +0.37% |
Figures last refreshed Oct 11, 2026.